Though these studies do not establish directly that CF inflammation is solely due to microtubule alterations, these studies in conjunction with previous work showing microtubule alterations in CF cells and the efficacy of HDAC6 depletion in reversing CF inflammation help support targeting microtubule regulation as an anti-inflammatory therapeutic target. This evidence concerns the gene HDAC6 and cystic fibrosis.